A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
Article in Journal of Virology (April 2024)
The most recent citing publications are shown below. View all 500 publications that cite this research output on Dimensions.
Article in Journal of Virology (April 2024)
Preprint in bioRxiv (March 2024)
Article in Virologica Sinica (March 2024)